Archives

Related Articles
Thyroglobulin polymorphisms in Tunisian patients with autoimmune thyroid diseases (AITD).
Immunobiology. 2008;213(7):577-83
Authors: Belguith-Maalej S, Hadj Kacem H, Rebai A, Mnif M, Abid M, Ayadi H

SAN FRANCISCO, CA (MARKET WIRE) Join head and neck surgeons, Dr. Lisa Orloff and Dr. David Terris, for a live webcast on technical advances in Parotidectomy and Minimally Invasive Thyroidectomy surgeries. The free one-hour live presentation is scheduled to take place at 3:00 p.m. PDT (6:00 p.m. EDT) from the University of California San Francisco Medical Center in San Francisco, California. (Source: Market Wire - Pharmaceuticals and Biotech)  

Abstract
Background  Hürthle cell neoplasms (HCNs) are rare tumors of the thyroid gland. The definitive treatment for Hürthle cell carcinoma (HCC)
is total thyroidectomy, while thyroid lobectomy is adequate for Hürthle cell adenoma (HCA). However, differentiating HCC from
HCA either before or during surgery is a challenge. The purpose of this study was to identify factors that predict malignancy
in patients with HCN.

Methods  Between May 1994 and January 2007, 1,199 patients underwent thyroid surgery at an academic medical center. Medical records